Keyphrases
Multiple Sclerosis
100%
Parkinson's Disease
60%
Experimental Autoimmune Encephalomyelitis
44%
Autoimmune Autonomic Ganglionopathy
39%
Amyotrophic Lateral Sclerosis
35%
Myasthenia Gravis
35%
Neuromyelitis Optica
34%
Central Nervous System
32%
Multiple Sclerosis Treatment
30%
Cerebrospinal Fluid
30%
Autoantibodies
30%
Japan
29%
Sema4D
27%
Aquaporin-4 (AQP4)
27%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
27%
Astrocytes
23%
Alpha-synuclein (α-syn)
20%
Inflammation
20%
Acetylcholine Receptor Antibody
20%
Japanese Patients
19%
Dopaminergic Neurons
18%
Semaphorin
18%
Anti-ganglionic Acetylcholine Receptor Antibodies
17%
Older Men
17%
Spinal Cord
17%
Nicotinic Acetylcholine Receptor (nAChR)
15%
DISC1
15%
Interferon-α (IFN-α)
15%
Demyelination
15%
Parkinson Patients
15%
Autonomic Dysfunction
15%
Clinical Features
14%
HTLV-1-associated Myelopathy
14%
Older Women
13%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
13%
Plasma Exchange
13%
P27Kip1
12%
Schizophrenia
12%
Beneficial Effects
12%
Prednisolone
12%
Inducible Nitric Oxide Synthase
12%
Cerebral Infarction
12%
Ganglionic Acetylcholine Receptor
11%
Patients with Parkinson's Disease
11%
Magnetic Resonance Imaging
11%
Plasmapheresis
11%
Neuronal Cells
11%
Density Dependence
11%
Murine Model
11%
Parkinson's Disease Model
10%
Neurodegenerative Diseases
10%
Non-valvular Atrial Fibrillation
10%
Cell Cycle Proteins
10%
Goshajinkigan
10%
Congenital Myasthenic Syndrome
10%
Idiopathic Parkinson's Disease
10%
Autoimmune Disease
10%
Autonomic Symptoms
10%
Myelopathy
10%
Substantia Nigra
9%
Disease Activity
9%
Methylprednisolone Pulse Therapy
9%
Intravenous Immunoglobulin (IVIg)
9%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
9%
Differential Diagnosis
9%
T Helper 17 (Th17)
9%
D-dimer
8%
Ganglioside GM3
8%
Bipolar Disorder
8%
Sjgren's Syndrome
8%
Transcranial Direct-current Stimulation (tDCS)
8%
Neurodegeneration
8%
Astrocytic
8%
Neurological Disorders
8%
Intravenous Immunoglobulin Therapy
8%
Demyelinating Diseases
8%
Immune Response
8%
Ischemic Stroke
8%
Neuroinflammation
8%
Mouse Model
8%
Neurite Outgrowth
8%
Encephalitis
8%
Magnetic Resonance Findings
8%
Autoimmune Encephalitis
8%
Phospholipase A2 (PLA2)
7%
Potential Biomarkers
7%
Polar Areas
7%
Lipoprotein Receptor-related Protein
7%
Expanded Disability Status Scale
7%
Astrocyte Proliferation
7%
Tumor Necrosis Factor-α
7%
Ataxia
7%
Encephalopathy
7%
PLA2G6
7%
Lower Limb
7%
Orthostatic Hypotension
7%
Cell-to-cell
7%
Calcium-independent Phospholipase A2
7%
Cyclooxygenase-2
7%
Induced Pluripotent Stem Cells (iPSCs)
7%
Neuroscience
Multiple Sclerosis
88%
Parkinson's Disease
66%
Neuromyelitis Optica
46%
Autoantibodies
31%
Central Nervous System
30%
Amyotrophic Lateral Sclerosis
27%
Astrocyte
26%
Experimental Autoimmune Encephalomyelitis
25%
Microglia
24%
Magnetic Resonance Imaging
22%
In Vitro
20%
Cholinergic Receptor Antibody
20%
Semaphorin
19%
Interferon
18%
Myasthenia gravis
18%
Dopaminergic Neuron
18%
Magnetic Resonance Imaging
17%
Dysautonomia
17%
Encephalitis
17%
Immunotherapy
16%
Neuropathy
15%
Cerebrovascular Accident
14%
Intravenous Immunoglobulin
14%
Cerebral Infarction
14%
Blood Plasma
13%
Cholinergic Receptor
13%
Adenosine Triphosphate
13%
Messenger RNA
12%
T Cell
12%
Aquaporin 4 Antibody
11%
Substantia nigra
11%
Nervous System Cell
11%
Synuclein
10%
Brain Disease
10%
Bipolar Disorder
10%
Ganglioside GM3
10%
Transcranial Direct Current Stimulation
10%
In Vivo
10%
Polyneuropathy
10%
Ataxia
10%
Autoimmune Disease
10%
Neurodegeneration
9%
Interleukin 6
9%
Muscle Disorder
9%
Necrosis
8%
Luciferase
8%
Atrial Fibrillation
8%
Neurodegenerative Disorder
8%
Neurological Disorder
8%
Transverse Myelitis
8%
Myelitis
8%
D Dimer
8%
Nicotinic Acetylcholine Receptor
8%
Neurite Outgrowth
8%
Electrical Brain Stimulation
8%
Fasciculation
8%
Differential Diagnosis
7%
Cognitive Disorders
7%
Lymphocyte
7%
Brain Ischemia
7%
Magnetic Resonance Imaging of Brain
7%
Immunoprecipitation
7%
Lipoprotein Receptor-Related Protein
7%
Dysarthria
7%
Cell Contact
7%
Tetrahydropyridine
7%
Protein Expression
7%
Stem Cell
7%
Positron Emission Tomography
7%
Calcium Independent Phospholipase A2
7%
Pericentrin
7%
Cyclooxygenase 2
7%
Infective Endocarditis
7%
Mitochondrial DNA
7%
Expression Analysis
7%
Cell Cycle Protein
7%
Zinc Finger
7%
Phospholipase A2
7%
Acute Disseminated Encephalomyelitis
7%
Spinal Cord Disease
7%
Reelin
7%
Amino Acid Activation
6%
Cyclin-Dependent Kinase
6%
Parkinsonism
6%
Cell Proliferation
6%
Antisense Oligonucleotide
6%
Receptor
6%
Tendon Reflex
6%
Brainstem
6%
Cognitive Function
6%
Blood Brain Barrier
5%
Heparin
5%
Febuxostat
5%
Nervous System Disorder
5%
Methylprednisolone
5%
Placebo
5%
Cell Survival
5%
Systemic Lupus Erythematosus
5%
Voltage Gated Calcium Channel
5%
Xanthine Oxidase
5%
Medicine and Dentistry
Magnetic Resonance Imaging
39%
Disease
38%
Parkinson's Disease
29%
Autoimmune Autonomic Ganglionopathy
25%
Cholinergic Receptor Antibody
23%
Encephalitis
18%
Myasthenia gravis
17%
Cerebrospinal Fluid
16%
Multiple Sclerosis
15%
Neurologic Disease
12%
Neuromyelitis Optica
12%
Atrial Fibrillation
11%
Demyelination
11%
Clinical Feature
11%
Biological Marker
11%
Neuropathy
10%
Brain Ischemia
10%
Autonomic Dysfunction
10%
Immunoglobulin
9%
Prednisolone
9%
Amyotrophic Lateral Sclerosis
9%
Plasma Exchange
9%
Autoantibodies
9%
Eaton Lambert Syndrome
8%
Paraneoplastic Cerebellar Degeneration
7%
Plasmapheresis
7%
Synuclein
7%
Lower Limb
7%
Pulse Rate
7%
Central Nervous System
7%
Infective Endocarditis
7%
Human T-Lymphotropic Virus 1
7%
Acute Disseminated Encephalomyelitis
7%
Spinal Cord Disease
7%
Messenger RNA
6%
Cholinergic Receptor
6%
Microglia
6%
Experimental Autoimmune Encephalomyelitis
6%
Ataxia
6%
In Vitro
6%
Limb
6%
Neurology
6%
Small Cell Lung Cancer
6%
Optic Neuritis
6%
Orthostatic Hypotension
6%
Antithrombotic
6%
Lymphocyte
6%
Electrical Brain Stimulation
6%
Dopaminergic Neuron
6%
Paresthesia
6%
Apoplexy
5%
Differential Diagnosis
5%
Immunotherapy
5%
Brain Disease
5%
Transverse Myelitis
5%
Dysarthria
5%
Weakness
5%
Alexander Disease
5%
Inducible Nitric Oxide Synthase
5%
Transcranial Direct Current Stimulation
5%
Drug Megadose
5%
Antisense Oligonucleotide
5%
Substantia nigra
5%
Leg
5%
Nicotinic Receptor
5%
Ophthalmoparesis
5%
Middle Cerebral Artery
5%
Brainstem
5%
Methylprednisolone
5%